Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Covington
AstraZeneca
Citi
Merck
Argus Health
Johnson and Johnson
Colorcon
McKinsey
Baxter

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,763,407

« Back to Dashboard

Summary for Patent: 5,763,407

Title: High-purity desmopressin produced in large single batches
Abstract:A process for the manufacture of high purity desmopressin produced in single batches of substantial size and a method of treating diabetes insipidus with the high purity desmopressin produced therefrom.
Inventor(s): Larsson; Krister (Malmo, SE), Mellbrand; Thomas (Malmo, SE), Mornstam; Birgitta (Bunkeflostrand, SE), Roschester; Jan (Lund, SE), Skoldback; Jan-Ake (Malmo, SE)
Assignee: Ferring BV (Hoofddorp, NL)
Application Number:08/797,826
Patent Claim Types:
see list of patent claims
Use; Formulation;

No matches for this query

International Patent Family for Patent: 5,763,407

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark0710243► Subscribe
European Patent Office0710243► Subscribe
Spain2149880► Subscribe
Greece3034405► Subscribe
Germany69424940► Subscribe
Mexico9710103► Subscribe
Austria193892► Subscribe
Portugal710243► Subscribe
World Intellectual Property Organization (WIPO)9501368► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
Healthtrust
Cipla
Daiichi Sankyo
Novartis
McKinsey
Johnson and Johnson
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot